Mawer Investment Management Ltd. Lowers Holdings in Ryan Specialty Holdings Inc. $RYAN

Mawer Investment Management Ltd. cut its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) by 5.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 469,456 shares of the company’s stock after selling 27,478 shares during the period. Mawer Investment Management Ltd. owned 0.18% of Ryan Specialty worth $26,459,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RYAN. Allspring Global Investments Holdings LLC acquired a new position in Ryan Specialty during the 2nd quarter worth $37,321,000. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Ryan Specialty by 2.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,387,108 shares of the company’s stock valued at $78,177,000 after buying an additional 33,588 shares during the period. Cooper Investors PTY Ltd. raised its holdings in Ryan Specialty by 33.9% in the 3rd quarter. Cooper Investors PTY Ltd. now owns 505,374 shares of the company’s stock valued at $28,483,000 after acquiring an additional 127,892 shares in the last quarter. Waters Parkerson & CO. LLC lifted its position in shares of Ryan Specialty by 4.3% in the 3rd quarter. Waters Parkerson & CO. LLC now owns 508,120 shares of the company’s stock worth $28,638,000 after acquiring an additional 20,920 shares during the period. Finally, Marshall Wace LLP grew its holdings in shares of Ryan Specialty by 142.1% during the 2nd quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after purchasing an additional 223,124 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Wall Street Analyst Weigh In

RYAN has been the topic of a number of recent research reports. The Goldman Sachs Group set a $61.00 price target on shares of Ryan Specialty in a research note on Wednesday, January 7th. TD Cowen reissued a “buy” rating on shares of Ryan Specialty in a research note on Wednesday, November 26th. Mizuho set a $60.00 price objective on Ryan Specialty in a report on Wednesday, January 14th. Piper Sandler initiated coverage on Ryan Specialty in a research note on Thursday, November 20th. They issued a “neutral” rating and a $60.00 price target on the stock. Finally, Jefferies Financial Group initiated coverage on shares of Ryan Specialty in a research report on Monday, December 1st. They set a “hold” rating and a $64.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of “Moderate Buy” and a consensus target price of $64.19.

View Our Latest Stock Report on Ryan Specialty

Ryan Specialty Trading Up 2.9%

NYSE RYAN opened at $48.70 on Monday. The stock has a market capitalization of $12.85 billion, a price-to-earnings ratio of 105.45, a PEG ratio of 1.22 and a beta of 0.62. Ryan Specialty Holdings Inc. has a 52 week low of $46.18 and a 52 week high of $77.16. The stock’s 50 day moving average price is $52.58 and its two-hundred day moving average price is $55.30. The company has a debt-to-equity ratio of 2.72, a quick ratio of 1.00 and a current ratio of 1.00.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.47 EPS for the quarter, hitting analysts’ consensus estimates of $0.47. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The business had revenue of $754.58 million during the quarter, compared to analysts’ expectations of $742.35 million. During the same quarter last year, the company posted $0.41 earnings per share. Ryan Specialty’s quarterly revenue was up 24.8% on a year-over-year basis. As a group, analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Insider Activity at Ryan Specialty

In related news, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the completion of the sale, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. This represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 52.21% of the company’s stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Recommended Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.